Adherence to guidelines across different specialties to prevent infections in patients undergoing immunosuppressive therapies.

ABSTRACT:

Background

Substantial numbers of patients are now receiving either immunosuppressive therapies or chemotherapy. There are significant risks in such patients of developing opportunistic infections or re-activation of latent infections, with higher associated morbidity and mortality. The aim of this quality improvement project was to determine how effective 5 different specialties were in assessing and mitigating risks of developing opportunistic infections or re-activation of latent infections in patients undergoing immunosuppressive therapies.

Methods

This was a single centre audit where records of patients attending clinics providing immunosuppressive therapies were reviewed for the following: evidence of screening for blood-borne virus [BBV] infections, varicella and meas

SUBMITTER: Chadwick DR 

PROVIDER: S-EPMC7238578 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature